Discovery of a multi-epitope tuberculosis vaccine targeting phospholipase C virulence factors: an insilico approach

Key Points

• The vaccine targeting phospholipase C aims to enhance the immune response against tuberculosis.
• In silico experiments reveal multi-epitope constructs that elicit strong immune responses.
• Assessment using computational modeling techniques efficiently identifies promising vaccine candidates.
• This approach may facilitate the development of effective tuberculosis vaccines, needing further experimental validation.